Novel Coronavirus (SARS-CoV-2/COVID-19)
For the last several months, disturbing and unproven theories have gained attention about the death count for COVID-19. We find these erroneous and egregious charges leveled against doctors 鈥 which have been repeated during the past few weeks 鈥 dismaying, disconcerting and disturbing.
AHA letter urging the Centers for Medicare & Medicaid Services to immediately withdraw the new condition of participation that threatens to expel hospitals from the Medicare program if they fail to comply with 鈥渇requently changing and confusing鈥 COVID-19 data collection efforts.
The Department of Health and Human Services issued an important clarification to its Oct. 22 reporting requirements for providers that received Provider Relief Fund payments.
Some health care needs are predictable but some are not. We can plan around giving birth, having a heart bypass, or scheduling a colonoscopy. But there are also surprises, such as injuries from accidents, or a cancer that appears with no family history 鈥 or COVID-19.
We鈥檝e been discussing for months how hospitals and health systems are contending with the worst financial crisis in their history as they continue to serve on the front lines of the fight against COVID-19.
In anticipation of the likely issuance of emergency use authorizations (EUAs) for at least two monoclonal antibody therapeutic drugs developed to treat certain COVID-19 positive patients, providers should begin planning for the distribution and administration process of these therapeutics.
The Centers for Medicare & Medicaid Services issued a final rule updating the home health prospective payment system for calendar year 2021.
The Federal Reserve Board reduced the minimum loan size for three Main Street Lending Program facilities from $250,000 to $100,000 and adjusted associated fees to support smaller organizations facing continued revenue shortfalls due to the pandemic.
This Special Bulletin details the Office of the National Coordinator (ONC) for Health Information Technology鈥檚 interim final rule with comment period to delay the Nov. 2 compliance date for the information blocking provisions of ONC鈥檚 Cures Act final rule, while also extending timelines for certain鈥
鈥淭he COVID-19 pandemic has proved that crisis tends to be a driver of innovation,鈥 writes Jonathan Bandel, vice president of strategy and innovation for New York鈥檚 White Plains Hospital.